WeedLife News Network
Japan unit of Britain's Jazz Pharma starts phase III trial of Cannabis
TOKYO - The Japanese unit of Britain's Jazz Pharmaceuticals PLC (JAZZ.O) said on Thursday it had started a phase III trial of a cannabis-based drug for epilepsy. The trial follows a recommendation by a health ministry panel in September to revise Japan's drug laws to allow for the importation and
Copyright
© 420 Intel
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.